Hydrafacial Results Presentation Deck
December 31, 2021 (unless otherwise stated)
Cash and Cash
Equivalents
Warrants
Convertible
Debt
Revolving Credit Facility
Shares Outstanding
I
Inclusive of the net proceeds of the convertible notes
2 As of 02/18/22
I
BALANCE SHEET HIGHLIGHTS
$901.9 million cash and cash equivalents on balance sheet¹
100% of Public Warrants exercised or redeemed by 11/05/21
Approximately 7 million Private Warrants outstanding
$750 million 1.25% convertible notes due 2026
Use of proceeds: capped call transaction, potential future acquisitions, working capital expenditures, and general corporate purposes
Conversion price of $31.76; capped call agreement provides dilution protection up to $47.94
$50 million Senior Secured Credit Facility borrowed by Edge Systems LLC (HydraFacial US operating entity); undrawn
Use of proceeds: working capital, general corporate purposes
Allows flexibility for future M&A; ex-US operations unencumbered; convertible debt excluded from covenants
25-35bps undrawn commitment fee
Weighted average shares outstanding of 146.3 million in Q4 2021
Approximately 150 million current shares outstanding2
Ample liquidity to pursue disciplined M&A and invest in the Beauty Health community
11View entire presentation